OnKure Therapeutics, Inc.
OKUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001637715
In the last 90 days, OnKure Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 75 institutions reported holding it in 13F filings for Q2 2026, worth $159.0M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in OnKure Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +2 vs. Q4 2021
- Shares held
- 17.3M
- −120.3K (−0.7%) vs. Q4 2021
- Total value
- $50.8M
- −$98.1M (−65.9%) vs. Q4 2021
- New holders
- 5
- 8 more added
- Sold out
- 3
- 13 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OKUR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $159.0M |
| Q1 2026 | 51 | $113.9M |
| Q4 2025 | 44 | $32.0M |
| Q3 2025 | 42 | $28.1M |
| Q2 2025 | 49 | $25.8M |
| Q1 2025 | 47 | $50.1M |
| Q4 2024 | 51 | $99.2M |
| Q3 2024 | 51 | $49.0M |
| Q2 2024 | 66 | $41.3M |
| Q1 2024 | 62 | $45.4M |
| Q4 2023 | 68 | $40.4M |
| Q3 2023 | 58 | $208.3M |
| Q2 2023 | 52 | $168.9M |
| Q1 2023 | 35 | $102.0M |
| Q4 2022 | 32 | $38.4M |
| Q3 2022 | 33 | $55.1M |
| Q2 2022 | 33 | $43.3M |
| Q1 2022 | 41 | $50.8M |
| Q4 2021 | 39 | $148.9M |
| Q3 2021 | 38 | $136.7M |
| Q2 2021 | 38 | $170.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding OnKure Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 494 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 760 | $2.00K | 0.00% | −1,869−71.1% | Reduced |
| Royal Bank of Canada | 533 | $2.00K | 0.00% | −1,582−74.8% | Reduced |
| Legal & General Group Plc | 700 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,067 | $3.00K | 0.00% | −1,595−59.9% | Reduced |
| STRS Ohio | 1,500 | $4.00K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,319 | $4.00K | 0.00% | +1,319 | New |
| Amalgamated Financial Corp. | 1,319 | $4.00K | 0.00% | +1,319 | New |
| Allspring Global Investments Holdings, LLC | 2,271 | $6.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 3,562 | $10.0K | 0.00% | +3,562 | New |
| California State Teachers Retirement System | 3,719 | $11.0K | 0.00% | −1,167−23.9% | Reduced |
| New York State Common Retirement Fund | 4,210 | $12.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 4,077 | $12.0K | 0.00% | +1,635+67.0% | Added |
| American International Group, Inc. | 4,316 | $13.0K | 0.00% | −303−6.6% | Reduced |
| Deutsche Bank AG | 4,722 | $14.0K | 0.00% | −560−10.6% | Reduced |
| Wells Fargo & Company | 5,364 | $16.0K | 0.00% | −2,615−32.8% | Reduced |
| Morgan Stanley | 5,409 | $16.0K | 0.00% | −1,739−24.3% | Reduced |
| FMR LLC | 6,289 | $18.0K | 0.00% | −30,411−82.9% | Reduced |
| Tower Research Capital LLC (TRC) | 9,800 | $29.0K | 0.00% | +8,561+691.0% | Added |
| Bank of New York Mellon Corp | 13,438 | $39.0K | 0.00% | −120−0.9% | Reduced |
| Federated Hermes, Inc. | 17,000 | $50.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 17,648 | $52.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 18,830 | $56.0K | 0.00% | 00.0% | Unchanged |
| Jefferies Group LLC | 21,328 | $62.7K | 0.00% | +21,328 | New |
| Commonwealth Equity Services, LLC | 22,347 | $65.0K | 0.00% | +22,347 | New |
| Bank of America Corp | 40,878 | $121.0K | 0.00% | +7,914+24.0% | Added |
| Northern Trust Corp | 68,424 | $201.0K | 0.00% | +4,877+7.7% | Added |
| State Street Corp | 89,253 | $262.0K | 0.00% | +1,190+1.4% | Added |
| Bridgeway Capital Management, LLC | 100,000 | $294.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 121,156 | $356.0K | 0.00% | +1,915+1.6% | Added |
| Ikarian Capital, LLC | 185,597 | $546.0K | 0.17% | +10,597+6.1% | Added |
| BlackRock Inc. | 317,027 | $932.0K | 0.00% | +1520.0% | Added |
| Vanguard Group Inc | 360,881 | $1.06M | 0.00% | −6,715−1.8% | Reduced |
| Franklin Resources Inc | 408,506 | $1.20M | 0.00% | −41,494−9.2% | Reduced |
| Tybourne Capital Management (HK) Ltd | 700,000 | $2.06M | 0.12% | −50,000−6.7% | Reduced |
| Aisling Capital Management LP | 886,075 | $2.60M | 1.41% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 1,143,185 | $3.36M | 0.08% | 00.0% | Unchanged |
| Abingworth LLP | 2,073,957 | $6.08M | 1.72% | 00.0% | Unchanged |
| RiverVest Venture Management LLC | 2,409,220 | $7.08M | 7.27% | 00.0% | Unchanged |
| Novo Holdings A/S | 3,430,377 | $10.1M | 0.53% | 00.0% | Unchanged |
| NEA Management Company, LLC | 4,786,921 | $14.1M | 0.45% | 00.0% | Unchanged |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −28,357−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −24,990−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,482−100.0% | Sold out |